NASDAQ : VOR
Vor Biopharma Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 19.53 USD (Oct 30, 2026, 2:45 PM EDT) · Market cap 1.16B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 73.55M | 43.48M | 27.88M | 31.72M | 28.87M | 21.49M |
| Research & Development | 74.17M | 298.46M | 93.31M | 94.31M | 64.55M | 47.53M |
| Operating Expenses | 147.71M | 341.94M | 121.19M | 126.04M | 93.42M | 69.02M |
| Operating Income | -147.71M | -341.94M | -121.19M | -126.04M | -93.42M | -69.02M |
| Interest & Investment Income | 15.68M | 5.87M | 4.27M | 8.17M | 1.32M | 119.00K |
| Other Non Operating Income (Expenses) | 1.51B | -334.36M | ||||
| EBT Excluding Unusual Items | 1.38B | -670.43M | -116.91M | -117.86M | -92.09M | -68.90M |
| Merger & Restructuring Charges | -29.71M | -29.71M | ||||
| Gain (Loss) on Sale of Assets | 4.15M | 4.15M | ||||
| Pretax Income | 1.35B | -695.98M | -116.91M | -117.86M | -92.09M | -68.90M |
| Net Income | 1.35B | -695.98M | -116.91M | -117.86M | -92.09M | -68.90M |
| Preferred Dividends & Other Adjustments | 1.23M | |||||
| Net Income to Common | 1.35B | -695.98M | -116.91M | -117.86M | -92.09M | -70.13M |
| Shares Outstanding (Basic) | 44.37M | 9.87M | 3.44M | 3.36M | 1.98M | 1.67M |
| Shares Outstanding (Diluted) | 44.37M | 9.87M | 3.44M | 3.36M | 1.98M | 1.67M |
| EPS (Basic) | 30.51 | -70.50 | -34.03 | -35.08 | -46.57 | -41.95 |
| EPS (Diluted) | 30.51 | -70.50 | -34.03 | -35.08 | -46.57 | -41.95 |
| Free Cash Flow | -119.68M | -143.65M | -99.89M | -101.36M | -93.61M | -73.04M |
| Free Cash Flow Per Share | -2.70 | -14.55 | -29.07 | -30.17 | -47.33 | -43.69 |
| EBITDA | -147.58M | -339.05M | -117.66M | -122.54M | -90.89M | -67.58M |
| D&A For EBITDA | 126.00K | 2.89M | 3.53M | 3.49M | 2.52M | 1.43M |
| EBIT | -147.71M | -341.94M | -121.19M | -126.04M | -93.42M | -69.02M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 78.98M | 396.49M | 81.95M | 31.36M | 57.71M | 119.80M |
| Short-Term Investments | 402.57M | 58.72M | 9.98M | 105.81M | 172.54M | 87.67M |
| Cash & Short-Term Investments | 481.55M | 455.21M | 91.93M | 137.18M | 230.25M | 207.47M |
| Prepaid Expenses | 4.97M | 1.15M | 4.20M | 3.15M | 4.37M | 4.84M |
| Other Current Assets | 4.00M | 1.75M | 380.00K | 475.00K | 2.34M | 2.09M |
| Total Current Assets | 490.52M | 458.11M | 96.51M | 140.80M | 236.95M | 214.40M |
| Property, Plant & Equipment | 3.23M | 3.47M | 41.59M | 50.10M | 57.08M | 22.52M |
| Other Long-Term Assets | 2.56M | 2.55M | 4.80M | 7.22M | 5.34M | 5.67M |
| Total Assets | 496.31M | 464.13M | 142.89M | 198.13M | 299.37M | 242.59M |
| Accounts Payable | 5.61M | 5.13M | 1.50M | 815.00K | 1.77M | 1.54M |
| Accrued Expenses | 30.36M | 19.76M | 12.89M | 10.93M | 8.07M | 6.33M |
| Current Portion of Leases | 370.00K | 280.00K | 4.21M | 3.83M | 3.27M | 1.84M |
| Other Current Liabilities | 434.00K | |||||
| Total Current Liabilities | 36.34M | 25.17M | 18.61M | 15.57M | 13.12M | 10.15M |
| Long-Term Leases | 2.44M | 2.72M | 27.61M | 31.83M | 35.64M | 16.17M |
| Other Long-Term Liabilities | 594.70M | 600.55M | ||||
| Total Liabilities | 633.49M | 628.44M | 46.23M | 47.40M | 48.76M | 26.33M |
| Common Stock | 20.00K | 18.00K | 13.00K | 7.00K | 7.00K | 4.00K |
| Additional Paid-In Capital | 1.39B | 988.60M | 553.62M | 490.87M | 473.59M | 346.38M |
| Retained Earnings | -1.52B | -1.15B | -456.99M | -340.08M | -222.22M | -130.12M |
| Comprehensive Income & Other | -1.84M | 41.00K | 22.00K | -77.00K | -770.00K | |
| Total Common Equity | -137.17M | -164.31M | 96.66M | 150.72M | 250.61M | 216.26M |
| Shareholders' Equity | -137.17M | -164.31M | 96.66M | 150.72M | 250.61M | 216.26M |
| Total Liabilities & Equity | 496.31M | 464.13M | 142.89M | 198.13M | 299.37M | 242.59M |
| Total Debt | 2.81M | 3.00M | 31.83M | 35.66M | 38.91M | 18.01M |
| Net Cash (Debt) | 478.74M | 452.21M | 60.10M | 101.52M | 191.33M | 189.46M |
| Net Cash Per Share | 10.79 | 45.81 | 17.49 | 30.22 | 96.75 | 113.33 |
| Filing Date Shares Outstanding | 61.43M | 48.85M | 6.24M | 3.41M | 3.32M | 1.87M |
| Total Common Shares Outstanding | 61.43M | 38.72M | 6.24M | 3.39M | 3.30M | 1.86M |
| Working Capital | 454.18M | 432.93M | 77.89M | 125.23M | 223.83M | 204.25M |
| Book Value Per Share | -2.23 | -4.24 | 15.49 | 44.40 | 75.95 | 116.35 |
| Tangible Book Value | -137.17M | -164.31M | 96.66M | 150.72M | 250.61M | 216.26M |
| Tangible Book Value Per Share | -2.23 | -4.24 | 15.49 | 44.40 | 75.95 | 116.35 |
| Machinery | 17.15M | 17.40M | 15.64M | 8.77M | ||
| Construction In Progress | 36.00K | 146.00K | 1.04M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 1.35B | -695.98M | -116.91M | -117.86M | -92.09M | -68.90M |
| Depreciation & Amortization | 126.00K | 2.89M | 3.53M | 3.49M | 2.52M | 1.43M |
| Loss (Gain) From Sale of Assets | 3.30M | -18.00K | ||||
| Asset Writedown & Restructuring Costs | 177.38M | |||||
| Stock-Based Compensation | 35.32M | 18.91M | 9.85M | 13.36M | 10.70M | 4.32M |
| Other Operating Activities | -1.52B | 340.58M | 3.89M | 67.00K | 3.57M | 3.19M |
| Change in Accounts Payable | 17.41M | 10.93M | 2.24M | 2.85M | 1.11M | 405.00K |
| Change in Other Net Operating Assets | -9.32M | -722.00K | -2.24M | -2.20M | -10.95M | -9.59M |
| Operating Cash Flow | -119.17M | -142.71M | -99.66M | -100.29M | -85.14M | -69.14M |
| Capital Expenditures | -507.00K | -941.00K | -229.00K | -1.07M | -8.46M | -3.89M |
| Sale of Property, Plant & Equipment | 799.00K | |||||
| Investment in Securities | -393.02M | -48.66M | 97.09M | 72.08M | -85.63M | -87.76M |
| Investing Cash Flow | -393.53M | -48.80M | 96.86M | 71.01M | -94.09M | -91.65M |
| Issuance of Common Stock | 606.92M | 505.39M | 56.05M | 4.84M | 117.14M | 189.75M |
| Repurchase of Common Stock | -345.00K | -254.00K | -333.00K | -1.19M | ||
| Other Financing Activities | -175.37M | -1.32M | -2.33M | -717.00K | -2.21M | |
| Financing Cash Flow | 431.21M | 503.81M | 53.39M | 2.94M | 117.14M | 232.91M |
| Net Cash Flow | -81.48M | 312.29M | 50.59M | -26.35M | -62.09M | 72.12M |
| Free Cash Flow | -119.68M | -143.65M | -99.89M | -101.36M | -93.61M | -73.04M |
| Free Cash Flow Per Share | -2.70 | -14.55 | -29.07 | -30.17 | -47.33 | -43.69 |
| Levered Free Cash Flow | -46.94M | -180.67M | -60.89M | -58.02M | -51.87M | -48.67M |
| Unlevered Free Cash Flow | -46.94M | -180.67M | -60.89M | -58.02M | -51.87M | -48.67M |
| Change in Working Capital | 8.10M | 10.21M | 5.00K | 650.00K | -9.84M | -9.19M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.19B | 506.46M | 138.24M | 152.56M | 436.57M | 433.30M |
| Enterprise Value | 713.08M | 339.06M | 108.29M | 29.06M | 340.80M | 224.95M |
| Last Close Price | 19.68 | 13.08 | 22.20 | 45.00 | 133.00 | 232.40 |
| PB Ratio | -3.08 | 1.43 | 1.01 | 1.74 | 2.00 | |
| P/TBV Ratio | 1.43 | 1.01 | 1.74 | 2.00 | ||
| Debt / Equity Ratio | -0.02 | -0.02 | 0.33 | 0.24 | 0.15 | 0.08 |
| Net Debt / Equity Ratio | 3.49 | 2.75 | -0.62 | -0.67 | -0.76 | -0.88 |
| Net Debt / EBITDA Ratio | 3.24 | 1.33 | 0.51 | 0.83 | 2.10 | 2.80 |
| Net Debt / FCF Ratio | 4.00 | 3.15 | 0.60 | 1.00 | 2.04 | 2.59 |
| Quick Ratio | 13.25 | 18.09 | 4.94 | 8.81 | 17.55 | 20.43 |
| Current Ratio | 13.50 | 18.20 | 5.18 | 9.04 | 18.06 | 21.12 |
| Return on Equity (ROE) | -94.52% | -58.74% | -39.45% | -52.09% | ||
| Return on Assets (ROA) | -27.45% | -70.41% | -44.42% | -31.67% | -21.55% | -27.09% |
| Return on Capital Employed (ROCE) | -32.10% | -77.90% | -97.50% | -69.00% | -32.60% | -29.70% |
| Earnings Yield | 157.28% | -137.42% | -84.57% | -77.25% | -21.09% | -15.90% |
| FCF Yield | -9.90% | -28.36% | -72.25% | -66.44% | -21.44% | -16.86% |
| Buyback Yield / Dilution | -682.04% | -187.35% | -2.26% | -69.88% | -18.30% | -15,547.86% |